Search

BackgroundMedical graduates from the universities of Oxford and Cambridge have a lower intention to become GPs compared with other UK medical graduates. It is not clear to what extent this difference is present on admission to medical school.AimTo compare the career intention and influencing factors of students on admission to different UK medical schools.Design & settingFirst year of a 6-year prospective cohort study of medical students admitted in autumn 2020 to the three East of England medical schools: University of East Anglia (UEA), University of Cambridge (UOC), and Anglia Ruskin University (ARU).MethodAn online survey instrument was administered at the beginning of the first year. This measured self-reported career interests and various influencing factors, including perceptions of general practice.ResultsUOC students declared a lower intention to become a doctor, a higher likelihood of choosing careers in pathology and public health, and a much lower likelihood of becoming a GP than students of UEA or ARU (all at PPConclusionUOC students’ lower intention to become a GP appears to be present on entry to medical school. This may be explained in part by these students placing a higher importance on research/academic opportunities, combined with the widely held perception that GP careers lack these opportunities.

In your editorial on obesity,1 Yates et al talk in apocalyptic terms about the rise in its prevalence. Their description of its ‘devastating consequences’ is amplified to an impressive degree by the repeated use of figures referring to relative rather than absolute risk. They propose an ‘urgent need for high quality research’ and go on to comment approvingly on the paper from the Bristol team,2 concluding that it provides evidence that ‘primary care can be used to engage effectively with, and manage, childhood obesity’. To be honest, I'm not that good at analysing research papers but I felt it would be worthwhile seeing whether the paper delivered on this promise. Unless I am missing something, the main results I can see from this paper are as follows: Of 152 eligible patients at the start of the trial, only 39 of them (25%) made it through to the end of the 12-month intervention period. Reductions in body mass index (BMI) seen in those who did last the course (in both the primary and secondary care groups) were modest to say the least — and the authors comment that the mean change in BMI ‘is too small to be certain of an improvement in metabolic health’. There is no follow up beyond the 12-month trial period to see if there is any sustained reduction in BMI. A more realistic conclusion, therefore, is that this model of an obesity clinic is equally ineffective in primary and secondary care. Something perhaps to bear in mind before we rush to provide such services as part of the ‘re-focusing of healthcare priorities’ that your editorial recommends.